PRESS RELEASE — In support of ongoing efforts to combat rising cases of syphilis, including congenital syphilis, the North Carolina Department of Health and Human Services is raising awareness among providers and patients of a recent rate increase to support treatment for Medicaid beneficiaries. As of Feb. 1, 2024, the Medicaid reimbursement rate has been increased to reflect the updated costs of the medication Bicillin L-A, which can be used to treat syphilis and is the only known effective treatment for preventing congenital syphilis.